3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
3SBio Inc (1530)
3SBio Inc stock price live, this page displays HK 1530 stock exchange data. View the 1530 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the 3SBio Inc real time stock price chart below.
What Is the 3SBio Inc Stock Price Today?
The 3SBio Inc stock price today is 16.36.
What Is the Stock Symbol for 3SBio Inc?
The stock symbol for 3SBio Inc is "1530."
What Stock Exchange Does 3SBio Inc Trade On?
3SBio Inc is listed and trades on the Hong Kong stock exchange.
Is 3SBio Inc a Good Stock to Buy?
Determining whether 3SBio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1530 quote. (ISIN: KYG8875G1029)
What Is the 3SBio Inc Stock Price Today?
The 3SBio Inc stock price today is 16.36.
What Is the Stock Symbol for 3SBio Inc?
The stock symbol for 3SBio Inc is "1530."
What Stock Exchange Does 3SBio Inc Trade On?
3SBio Inc is listed and trades on the Hong Kong stock exchange.
Is 3SBio Inc a Good Stock to Buy?
Determining whether 3SBio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1530 quote. (ISIN: KYG8875G1029)
16.36
-0.51(-3.02%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.13
16.91
52 wk Range
16.13
36.80
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.1316.91
52 wk Range
16.1336.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.53%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1530 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
37.56
Upside
+129.57%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 37.56
(+129.57% Upside)
Earnings
Latest Release
Mar 30, 2026
EPS / Forecast
2.85 / --
Revenue / Forecast
13.34B / --
Compare 1530 to Peers and Sector
Metrics to compare | 1530 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1530PeersSector | |
|---|---|---|---|---|
P/E Ratio | 4.2x | 28.4x | −0.5x | |
PEG Ratio | 0.01 | 0.11 | 0.00 | |
Price/Book | 1.3x | 2.3x | 2.6x | |
Price / LTM Sales | 2.0x | 4.7x | 3.1x | |
Upside (Analyst Target) | 113.6% | 48.9% | 57.1% | |
Fair Value Upside | Unlock | 23.1% | 10.1% | Unlock |
3SBio Inc., an investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally. The company offers TPIAO bio-pharmaceutical drug for the treatment of chemotherapy-induced thrombocytopenia, immune thrombocytopenia, pediatric ITP, and chronic liver disease-related thrombocytopenia. It also provides EPIAO for indications, such as the treatment of anemia associated with chronic kidney disease, chemotherapy-induced anemia, and the reduction of allogeneic blood transfusion in surgery patients; and Yisaipu, a TNF-a inhibitor product for rheumatoid arthritis, ankylosing spondylitis, and psoriasis indications. In addition, the company offers Cipterbin, an anti-HER2 mAb for treatment of HER2-positive metastatic breast cancer in combination with chemotherapy; and Mandi, a minoxidil tincture for androgenetic alopecia and alopecia areata. Further, it develops 608, an anti-IL-17A mAb; SSS20 for patients with ITP and severe Aplastic Anemia; SSS06 for the treatment of adult dialysis patients undergoing erythropoietin therapy with a biweekly dosing interval; 613, for the treatment of acute gouty arthritis; 611, an anti-IL-4R a mAb; and 601A, an anti-VEGF mAb. Additionally, the company is involved in manufacture and sale of pharmaceutical drugs; business management; provision of technical services, investment advisory services, financial services, sports services, clinic services, technology services, and agricultural services; retail of pharmaceuticals; and enterprise management consulting. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the 3SBio (1530) Stock Price Today?
The 3SBio stock price today is 16.36 HKD.
What Stock Exchange Does 3SBio Trade On?
3SBio is listed and trades on the Hong Kong Stock Exchange.
What Is the Stock Symbol for 3SBio?
The stock symbol for 3SBio is "1530."
Does 3SBio Pay Dividends? What’s The Current Dividend Yield?
The 3SBio dividend yield is 1.53%.
What Is the 3SBio Market Cap?
As of today, 3SBio market cap is 42.19B HKD.
What Is 3SBio's Earnings Per Share (TTM)?
The 3SBio EPS (TTM) is 3.43.
From a Technical Analysis Perspective, Is 1530 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has 3SBio Stock Split?
3SBio has split 0 times.
How Many Employees Does 3SBio Have?
3SBio has 6109 employees.
What is the current trading status of 3SBio (1530)?
As of Jun 03, 2026, 3SBio (1530) is trading at a price of 16.36 HKD, with a previous close of 16.87 HKD. The stock has fluctuated within a day range of 16.13 HKD to 16.91 HKD, while its 52-week range spans from 16.13 HKD to 36.80 HKD.
What Is 3SBio (1530) Price Target According to Analysts?
The average 12-month price target for 3SBio is 37.56 HKD, with a high estimate of 50.33344911 HKD and a low estimate of 25.97892787 HKD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +129.57% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.